WILLIAM H. ALSUP, District Judge.
WHEREAS, on May 24, 2016, Illumina, Inc. and Illumina Cambridge Ltd. (together, "Illumina") filed its Complaint [Dkt. No. 1] and Motion for Preliminary Injunction [Dkt. No. 13] against defendants QIAGEN N.V., QIAGEN GmbH, QIAGEN Gaithersburg, Inc., QIAGEN Sciences, LLC, QIAGEN Inc. (USA), QIAGEN Redwood City, Inc., and Intelligent Bio-Systems, Inc. (together, "QIAGEN");
WHEREAS, the parties stipulated and the Court ordered that the deadline for QIAGEN to respond to Illumina's Complaint and Motion for Preliminary Injunction be extended until and including June 17, 2016 to allow the parties time to engage in further discussions regarding the efficient resolution of the parties' disputes;
WHEREAS, the parties have previously jointly filed a Notice of Pendency of a Related Case [Dkt. No. 27], notifying the Court of the case Tr. of Columbia Univ. in the City of N.Y. v. Illumina, Inc., No. 12-cv-0376 (U.S.D.C. D. Del.) (Sleet, J.), and the intention of the QIAGEN defendants to move to transfer this case to the District of Delaware;
WHEREAS, the QIAGEN defendants except for QIAGEN N.V. have now filed a motion to transfer this matter to the District of Delaware [Dkt. No. 29], and QIAGEN N.V. intends to file on or before June 16, 2016, a motion to dismiss QIAGEN N.V. from this case for lack of personal jurisdiction;
WHEREAS, Illumina intends to oppose these motions;
NOW THEREFORE, the parties HEREBY STIPULATE AND AGREE, subject to the approval and order of the Court, as follows:
d. The parties respectfully request that, if the Court plans to hold a hearing for this motion, that it be set for
QIAGEN believes that it will be filing an additional declaration or declarations with its Reply, it shall notify the Court and Illumina by June 30, and Illumina agrees that QIAGEN's Reply in such a circumstance is due on or before
d. The parties respectfully request that, if the Court plans to hold a hearing for this motion, that it be set for
a. Reserving all defenses they may have, the QIAGEN defendants other than QIAGEN N.V. will limit their response to the Complaint to an answer, affirmative defenses, and any counterclaims, and such answers to the complaint will be due on the day that is 7 business days after the Court's decision on QIAGEN's Motion to Transfer.
a. If the Court has not granted QIAGEN's motion to transfer as of
b. If this case is transferred to Delaware, and the parties have not completed the preliminary injunction briefing yet, they will diligently negotiate a schedule for the prompt completion of briefing in Delaware.
a. Pursuant to Civil Local Rule 7-7, Illumina hereby requests to continue the originally noticed hearing date of July 21, 2016 for its preliminary injunction motion to
I, John L. Cooper, represent that concurrence in the filing of this document has been obtained from each of the other signatories, which shall serve in lieu of their signatures on this document.
PURSUANT TO STIPULATION, IT IS SO ORDERED.